top of page
Phone: 888-855-0947 Office Hours: M-F 10am-6pm Fax: 346-766-0599
After hours: If urgent, life threatening (please call 988, 911, or go to nearest ER. Otherwise, for side effects to medications, please text 816-766-0119. For all other non-urgent issues, please contact us Practice Q messaging portal or contact us during clinic hours at 888-855-0947.
two women talking and smiling
a boy bow down on floor
a women crying while holding a hand
two women talking and smiling
1/3
Ready for your Mental Health Transformation?
Child Psychiatrist /Adult Psychiatrist
Blog
Search
Why Generosity is a Psychoexemplary
PSYCHIATRIC VIEWS ON THE DAILY NEWS In his commencement speech at Brandeis, and as noted in our recent column on statesmanship, the...
Vilash Reddy, MD
Jun 11, 20242 min read
1
0
High Confidence Alzheimer's Drug Donanemab Will Get FDA Panel Nod
The Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug Administration (FDA) will meet on June 10 to...
Vilash Reddy, MD
Jun 11, 20244 min read
0
0
Neuroplasticity After Brain Injury: Principles and Methods for Postinjury Improvement
Keypoint: Improving cognitive function is a primary goal of brain injury rehabilitation and is made possible through the process of...
Vilash Reddy, MD
Jun 11, 20246 min read
3
0
Efficacy of Brexpiprazole and Sertraline for the Treatment of PTSD
Keypoint: A poster at the 2024 ASCP Annual Meeting shared data from 3 randomized clinical trials on the safety and tolerability of this...
Vilash Reddy, MD
Jun 7, 20243 min read
10
0
Polypharmacy in Older Adults
Keypoint: Clinicians should carefully weigh the risks and benefits of each prescribed medication for an older adult with neuropsychiatric...
Vilash Reddy, MD
Jun 7, 20247 min read
0
0
Brain Scans After Memory Shifts May Show Alzheimer's Risk
May 30, 2024 — Older people at high risk of Alzheimer's disease who reported significant memory problems during the past year were more...
Vilash Reddy, MD
Jun 7, 20243 min read
0
0
What to Expect if MDMA-Assisted Psychotherapy Gets Approved by the FDA
3,4-Methylenedioxymethamphetamine (MDMA) is a psychopharmacological agent with effects that include the enhancement of empathy, prosocial...
Vilash Reddy, MD
Jun 6, 20244 min read
2
0
Evaluating the Efficacy of Lumateperone for MDD and Bipolar Depression With Mixed Features
Keypoint: A poster presented at the 2024 ASCP Annual Meeting discussed the results of a study analyzing the treatment’s safety and...
Vilash Reddy, MD
Jun 6, 20243 min read
2
0
Critical Care Psychiatry: The Value of Psychiatrists in the ICU
Keypoint: In this CME article, learn more about common clinical conditions, consultation questions, and challenges in the field of...
Vilash Reddy, MD
Jun 5, 202413 min read
16
0
Teen Cannabis Use Tied to Dramatic Increased Risk for Psychosis
Teenagers who use cannabis have a dramatic increased risk for a psychotic disorder compared with their counterparts who don't use the...
Vilash Reddy, MD
Jun 5, 20243 min read
3
0
Physician Burnout by Specialty & Other Physician Mental Health Statistics
In the wake of the COVID-19 pandemic, physicians continue to experience burnout at alarmingly high rates. In a recent survey of 2440...
Vilash Reddy, MD
Jun 5, 20244 min read
3
0
Maternal Buprenorphine Affects Fetal Breathing
SAN FRANCISCO — Measures of fetal breathing movement were lower in fetuses of pregnant patients who received buprenorphine, compared with...
Vilash Reddy, MD
Jun 4, 20242 min read
0
0
Promising Topline Results for Drug to Treat Concomitant Depression and Insomnia
Seltorexant, an investigational drug being developed by Johnson & Johnson, met all primary and secondary endpoints in a phase 3 trial of...
Vilash Reddy, MD
Jun 4, 20242 min read
2
0
Revisiting Modafinil/Armodafinil for the Treatment of Bipolar Disorder
Keypoint: An expert shares some lessons learned from prior research on the treatment and suggestions for a way forward at the 2024 ASCP...
Vilash Reddy, MD
Jun 4, 20243 min read
4
0
Neuropsychiatric Symptoms an Important, Overlooked Feature of Lupus
Neuropsychiatric symptoms, including nightmares and hallucinatory "daymares," may be a more important aspect of systemic lupus...
Vilash Reddy, MD
Jun 4, 20248 min read
3
0
DOJ Officially Moves to Reclassify Marijuana as Schedule III
The US Department of Justice (DOJ) officially moved to reclassify marijuana as a Schedule III controlled substance on Thursday, marking a...
Vilash Reddy, MD
Jun 3, 20242 min read
1
0
How to Treat Alcohol Use Disorder in Patients With Liver Disease
For many people navigating the stresses of the COVID-19 pandemic, temporary relief came in the form of a stiff drink. In the United...
Vilash Reddy, MD
Jun 3, 20246 min read
0
0
New Data on Psychiatric Polypharmacy and Unwanted Weight Gain
Keypoint: A recent study analyzed longitudinal data of patients with schizophrenia or major depressive disorder to rank treatment...
Vilash Reddy, MD
May 30, 20243 min read
2
0
Longitudinal Study Looks at Risk of Cardiovascular Disease With Long-Term ADHD Medication Use
Keypoint: A study assessed the associations between the use of ADHD medications and CVD over the course of 14 years. Here's what the...
Vilash Reddy, MD
May 30, 20244 min read
1
0
When It Comes to Medicine, ‘Women Are Not Small Men’
Welcome everyone. I'm Dr. John White. I'm the chief medical officer at WebMD. Does your biologic sex impact your health? Does it have any...
Vilash Reddy, MD
May 30, 20245 min read
1
0
bottom of page